Keratoconjunctivitis in a group of Icelandic horses with suspected
c-herpesvirus involvement
J. O. RUSHTON, J. KOLODZIEJEK
†
, B. NELL, H. WEISSENB
€
OCK
‡
and N. NOWOTNY*
†§
Department of Companion Animals and Horses, University of Veterinary Medicine Vienna, Austria
†
Institute of Virology, University of Veterinary Medicine Vienna, Austria
‡
Institute of Pathology and Forensic Veterinary Medicine, University of Veterinary Medicine Vienna, Austria
§
Department of Microbiology and Immunology, College of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Oman.
*Correspondence emails: nowotny@squ.edu.om; norbert.nowotny@vetmeduni.ac.at; Received: 07.02.15; Accepted: 26.05.15
Summary
Reasons for performing study: The role of equid c-herpesviruses on ocular surface diseases has been disputed, because the diagnosis is usually
based on clinical symptoms and detection of viral DNA from samples obtained from live animals.
Objectives: To describe the clinical course, results of polymerase chain reaction (PCR) analysis, in situ hybridisation, cell culture and pathohistological
findings of select cases in a presumed outbreak of herpesvirus infection in a group of 15 Icelandic horses.
Study design: Case series.
Methods: Pooled ocular and nasal swabs and peripheral blood mononuclear cells of horses diagnosed clinically with herpesvirus-associated
keratoconjunctivitis were analysed for presence of equine herpesviruses (EHV)-2 and EHV-5 nucleic acid using real-time PCR. Necropsy specimens from
one horse, subjected to euthanasia due to deterioration of clinical symptoms were examined histopathologically, and analysed for presence of EHV-2
and EHV-5 nucleic acid using real-time PCR. In situ hybridisation and cell culture of select samples were performed.
Results: All horses with symptoms of severe keratoconjunctivitis were positive for presence of either EHV-2 and/or EHV-5 nucleic acid using real-time
PCR. Assessment of necropsy specimens of the most severely affected case, revealed presence of EHV-2 and/or EHV-5 nucleic acid in several ocular
and extraocular anatomical locations. The remaining horses responded favourably to symptomatic treatment.
Conclusions: This case series illustrates a severe outbreak of keratoconjunctivitis in a group of Icelandic horses, with suspected c-herpesvirus
involvement. For the first time equid c-herpesviruses were detected in intraocular anatomical locations.
Keywords: horse; EHV-2; EHV-5; gammaherpesviruses; Icelandic horse; keratoconjunctivitis
Introduction
Since the first reports of outbreaks of equid herpesvirus-2 (EHV-2)
induced keratoconjunctivitis in horses [1,2], the role of c-herpesviruses
on the development of ocular disease has been subject to extensive
investigation [3–8]. However, to date the exact pathogenesis of
herpesvirus induced keratoconjunctivitis is undetermined. The ubiquitous
nature and the potential for latent infection of c-herpesviruses, as well
as the influence of host immune response on the development of
clinical disease, render experimental studies difficult to perform
[3,4,9,10]. However, despite the drawbacks in experimental studies, the
influence of c-herpesviruses on the development of ocular diseases
cannot be disregarded.
Clinical history
An outbreak of sudden-onset keratoconjunctivitis in a group of 15 Icelandic
horses aged between approximately one and 3 years was reported to the
ophthalmology unit of the University of Veterinary Medicine Vienna.
Symptomatic treatment with topical antibiotics (not specified) and systemic
nonsteroidal anti-inflammatory drugs (NSAIDs; not specified) was initiated
by the referring veterinarian.
Physical examination and ophthalmological findings
All horses had mucopurulent ocular, nasal discharge and corneal
oedema of various severity. Corneal ulceration was not detected by
uptake of fluorescein stain at the time of initial examination in any
horse. Horses more severely affected showed blepharospasm. All
animals were reported to have been febrile, but no fevers were
detected, presumably due to the systemic administration of NSAIDs. The
remainder of the complete physical examination of the animals was
within normal limits.
Laboratory investigations
Due to the large number of affected animals and financial constraints of
the owners, ocular and nasal swabs and whole blood of only the five most
severely affected animals were obtained and submitted for further
diagnostic work-up. Based on the course of disease and the clinical
presentation a viral agent was suspected. Conjunctival swabs were taken
from the most severely affected horse and submitted for bacterial and
fungal cultures, revealing moderate amounts of commensal bacterial and
fungal flora with no predominant microbial agents. Extracted DNA samples
of ocular and nasal swabs and peripheral blood mononuclear cells of each
horse were pooled and analysed for the presence of EHV-2 using methods
described in earlier reports [3]. All horses were positive for EHV-2 with real-
time polymerase chain reaction (PCR) analysis.
Treatment and clinical progress
All horses were treated with topical trifluridine (Virophtha
a
) t.i.d.
Re-evaluation of affected animals 1 week later revealed marked
improvement of ocular signs. Treatment, however, was continued.
Re-examination of the horses 2 weeks after initial presentation revealed
significant improvement in all horses except one, which had developed
bilateral melting corneal ulcers in the temporal half of the cornea (Fig 1).
This animal was hospitalised on the same day. Cytology of ocular scrapings
was performed to rule out the presence of fungal or bacterial pathogens.
No intracellular bacteria or fungal hyphae were identified upon cytology.
Treatment consisted of systemic NSAIDs (Finadyne
b
1.1 mg/kg bwt s.i.d.),
as well as topical serum and EDTA every other hour, topical trifluridine,
natamyicin (Infektomyk
c
), neomycin-polymyxin-bacitracin (Polyspektran
d
) six
times daily and topical atropine (Atropin
e
) s.i.d. Due to financial constraints
bilateral placement of conjunctival pedical grafts was not an option.
Despite intensive treatment over 10 days, there was no significant
improvement and the horse was subjected to euthanasia.
Equine Veterinary Journal 48 (2016) 427–429 © 2015 EVJ Ltd 427
Equine Veterinary Journal ISSN 0425-1644
DOI: 10.1111/evj.12465